Federal Register / Vol. 80, No. 43 / Thursday, March 5, 2015 / Notices 11999 

used if such approach satisfies the 

requirements of the applicable statutes 

and regulations. 

II. The Paperwork Reduction Act of 

1995 

This guidance refers to previously 

approved collections of information that 

are subject to review by the Office of 

Management and Budget (OMB) under 

the Paperwork Reduction Act of 1995 

(44 U.S.C. 3501–3520). The collections 

of information in 21 CFR parts 312 and 

314 have been approved under OMB 

control numbers 0910–0014 and 0910– 

0001, respectively. 

III. Comments 

Interested persons may submit either 

electronic comments regarding this 

document to http://www.regulations.gov 

or written comments to the Division of 

Dockets Management (see ADDRESSES). It 

is only necessary to send one set of 

comments. Identify comments with the 

docket number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday, and 

will be posted to the docket at http://

www.regulations.gov. 

IV. Electronic Access 

Persons with access to the Internet 

may obtain the document at http://www.

fda.gov/Drugs/GuidanceCompliance

RegulatoryInformation/Guidances/ 

default.htm, http://www.fda.gov/

BiologicsBloodVaccines/Guidance

ComplianceRegulatoryInformation/

default.htm, or http://

www.regulations.gov. 

Dated: February 27, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–05016 Filed 3–4–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Solicitation of Written Comments on 

the Draft National Adult Immunization 

Plan; Extension of Comment Period 

AGENCY: National Vaccine Program 

Office, Office of the Assistant Secretary 

for Health, Office of the Secretary, 

Department of Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS), through the 

National Vaccine Program Office 

(NVPO) is extending the public 

comment period for a draft document 

titled ‘‘The National Adult 

Immunization Plan (NAIP).’’ The 

availability of that draft document was 

published in the Federal Register on 

February 6, 2015, Volume 80, Number 

25, pages 6721–6722. 

DATES: The comment period is extended 

by 14 days and thus will end on March 

23, 2015. 

ADDRESSES: (1) The draft NAIP is 

available on the Web at www.hhs.gov/

nvpo/. 

(2) Electronic responses are preferred 

and may be addressed to: Rebecca.Fish@

hhs.gov. 

(3) Written responses should be 

addressed to: National Vaccine Program 

Office, U.S. Department of Health and 

Human Services, 200 Independence 

Avenue SW., Room 733G, Washington, 

DC 20201. 

FOR FURTHER INFORMATION CONTACT: 

Rebecca Fish, National Vaccine Program 

Office, Office of the Assistant Secretary 

for Health, Department of Health and 

Human Services; telephone (202) 260– 

9283; fax (202) 260–1165; email: 

Rebecca.Fish@hhs.gov. 

SUPPLEMENTARY INFORMATION: The notice 

of availability of the draft National 

Adult Immunization Plan (NAIP) was 

published in the Federal Register on 

February 6, 2015, Volume 80, Number 

25, pages 6721–6722, with a deadline 

for comments of March 9, 2015. The 

NAIP is a national plan that will require 

engagement from a wide range of 

stakeholders to achieve its full vision. 

The plan emphasizes collaboration and 

prioritization of efforts that will have 

the greatest impact. NVPO is soliciting 

public comment on the draft NAIP from 

a variety of stakeholders, including the 

general public, for consideration as they 

develop their final report to the 

Secretary. Since the notice of 

availability and draft guidance 

documents were published, the 

Department has received requests to 

extend the comment period to allow 

sufficient time for a full review of the 

draft NAIP. NVPO is committed to 

affording the public a meaningful 

opportunity to comment on the draft 

NAIP and welcomes comments. 

Persons with access to the Internet 

may obtain the draft National Adult 

Immunization Plan on NVPO’s Web site 

at http://www.hhs.gov/nvpo. 

Dated: February 25, 2015. 

Bruce Gellin, 

Deputy Assistant Secretary for Health, 

Director, National Vaccine Program Office, 

Executive Secretary, National Vaccine 

Advisory Committee. 

[FR Doc. 2015–05030 Filed 3–4–15; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Gene 

Regulation. 

Date: February 26, 2015. 

Time: 1:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Richard A Currie, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1108, 

MSC 7890, Bethesda, MD 20892, (301) 435– 

1219, currieri@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Topics in 

Biomaterials. 

Date: March 5–6, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Joseph D Mosca, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5158, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

2344, moscajos@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

mstockstill on DSK4VPTVN1PROD with NOTICES